A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...

Breast cancer, the number one female cancer in Korea, is divided into several types depending on the presence or absence of ...

A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled “Bridging clinical insight and ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Although frontline maintenance treatment with fuzuloparib monotherapy produced a progression-free survival (PFS) benefit in patients with newly diagnosed advanced ovarian cancer, the addition of ...

Long before opioids flooded communities, something else was quietly changing—and it may have helped set the stage for today’s ...

In the future, medicines made from cannabis could help fight ovarian cancer. A research team studying two natural chemicals ...

Here are the top 5 ovarian cancer articles of 2025; stay up-to-date with all the ovarian cancer content from The American ...

Ahmedabad-based Zydus Lifesciences Ltd has inked a pact with precision diagnostics company Myriad Genetics from the USA to introduce globally validated cancer-risk assessment and prognostic tests in ...

Laboratory studies have found that a combination of THC and CBD can kill ovarian cancer cells without harming healthy cells. Researchers are exploring whether future cancer treatments could be ...

A new American Cancer Society report reveals deep cancer mortality disparities across the U.S., with rural communities, lower ...

Preliminary research indicates cannabis compounds cannabidiol and Δ9-tetrahydrocannabinol could have potential in treating ...